Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Leach

Showing results (281-290 of 326) with videos related to

Pageof 33
Sort By:
Molecular Cancer Research : MCR|May 15, 2014
VDR activity is differentially affected by Hic-5 in prostate cancer and stromal cellsJoshua D Solomon, Marjet D Heitzer, Teresa T Liu, et al.
The Journal of Infectious Diseases|March 1, 1995
A trial of a group A plus group C meningococcal polysaccharide-protein conjugate vaccine in African infantsP A Twumasi, S Kumah, A Leach, et al.
Journal of Medicinal Chemistry|February 1, 1990
Reversible inhibitors of the gastric (H+/K+)-ATPase. 1. 1-Aryl-4-methylpyrrolo[3,2-c]quinolines as conformationally restrained analogues of 4-(arylamino)quinolinesT H Brown, R J Ife, D J Keeling, et al.
Journal of Medicinal Chemistry|September 4, 1992
Reversible inhibitors of the gastric (H+/K+)-ATPase. 3. 3-substituted-4-(phenylamino)quinolinesR J Ife, T H Brown, D J Keeling, et al.
Nature Communications|July 2, 2021
The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cellsD A Leach, A Mohr, E S Giotis, et al.
International Journal of Cancer|June 7, 2013
Knockdown of the cochaperone SGTA results in the suppression of androgen and PI3K/Akt signaling and inhibition of prostate cancer cell proliferationAndrew P Trotta, Eleanor F Need, Luke A Selth, et al.
Molecular and Cellular Endocrinology|November 13, 2016
Peroxidase enzymes inhibit osteoclast differentiation and bone resorptionVasilios Panagopoulos, Vasilios Liapis, Irene Zinonos, et al.
BMC Cancer|October 27, 2015
The unique transcriptional response produced by concurrent estrogen and progesterone treatment in breast cancer cells results in upregulation of growth factor pathways and switching from a Luminal A to a Basal-like subtypeEleanor F Need, Luke A Selth, Andrew P Trotta, et al.
Endocrine Oncology (Bristol, England)|July 11, 2025
Thieno[2,3-<i>b</i>]pyridine compounds potently inhibit prostate cancer growth and motilityM A Alkheilewi, D A Leach, A Mohr, et al.
The Journal of Endocrinology|January 9, 2023
Apoptosis-modulatory miR-361-3p as a novel treatment target in endocrine-responsive and endocrine-resistant breast cancerJ N Zamarbide Losada, E Sulpice, S Combe, et al.
Pageof 33

Showing results (281-290 of 326) with videos related to

Sort By:
Pageof 33
Molecular Cancer Research : MCR|May 15, 2014
VDR activity is differentially affected by Hic-5 in prostate cancer and stromal cellsJoshua D Solomon, Marjet D Heitzer, Teresa T Liu, et al.
The Journal of Infectious Diseases|March 1, 1995
A trial of a group A plus group C meningococcal polysaccharide-protein conjugate vaccine in African infantsP A Twumasi, S Kumah, A Leach, et al.
Journal of Medicinal Chemistry|February 1, 1990
Reversible inhibitors of the gastric (H+/K+)-ATPase. 1. 1-Aryl-4-methylpyrrolo[3,2-c]quinolines as conformationally restrained analogues of 4-(arylamino)quinolinesT H Brown, R J Ife, D J Keeling, et al.
Journal of Medicinal Chemistry|September 4, 1992
Reversible inhibitors of the gastric (H+/K+)-ATPase. 3. 3-substituted-4-(phenylamino)quinolinesR J Ife, T H Brown, D J Keeling, et al.
Nature Communications|July 2, 2021
The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cellsD A Leach, A Mohr, E S Giotis, et al.
International Journal of Cancer|June 7, 2013
Knockdown of the cochaperone SGTA results in the suppression of androgen and PI3K/Akt signaling and inhibition of prostate cancer cell proliferationAndrew P Trotta, Eleanor F Need, Luke A Selth, et al.
Molecular and Cellular Endocrinology|November 13, 2016
Peroxidase enzymes inhibit osteoclast differentiation and bone resorptionVasilios Panagopoulos, Vasilios Liapis, Irene Zinonos, et al.
BMC Cancer|October 27, 2015
The unique transcriptional response produced by concurrent estrogen and progesterone treatment in breast cancer cells results in upregulation of growth factor pathways and switching from a Luminal A to a Basal-like subtypeEleanor F Need, Luke A Selth, Andrew P Trotta, et al.
Endocrine Oncology (Bristol, England)|July 11, 2025
Thieno[2,3-<i>b</i>]pyridine compounds potently inhibit prostate cancer growth and motilityM A Alkheilewi, D A Leach, A Mohr, et al.
The Journal of Endocrinology|January 9, 2023
Apoptosis-modulatory miR-361-3p as a novel treatment target in endocrine-responsive and endocrine-resistant breast cancerJ N Zamarbide Losada, E Sulpice, S Combe, et al.
Pageof 33